A new study from Kaiser Permanente adds growing concern about retinal toxicity from Elmiron, an FDA-approved drug to treat interstitial cystitis.
A new study from Kaiser Permanente adds growing concern about retinal toxicity from Elmiron, an FDA-approved drug to treat interstitial cystitis.